Carotid Artery Stenting Versus Carotid Endarterectomy for Asymptomatic Carotid Stenosis: A Propensity Score–Matched Real-World Analysis

BACKGROUND AND OBJECTIVES: Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are established revascularization strategies for carotid stenosis, yet evidence comparing them in asymptomatic populations remains limited. The Carotid Revascularization Endarterectomy versus Stenting Trial-2 used a parallel-arm design and did not provide a direct head-to-head comparison of CAS vs CEA. This study evaluates real-world long-term outcomes of CAS compared directly with those of CEA in asymptomatic carotid stenosis. METHODS: Adults with asymptomatic carotid stenosis undergoing CAS or CEA between January 2016 and December 2024 were identified from the TriNetX US Collaborative Network. Patients with previous ischemic stroke, TIA, hemorrhage, or posterior-circulation stenosis were excluded. Propensity score matching (1:1) on demographics, comorbidities, and baseline antithrombotic medications yielded 5415 patients per cohort. Primary outcomes were all-cause mortality and ischemic stroke at 5 years; secondary outcomes included intraparenchymal hemorrhage and major bleeding. Kaplan-Meier analyses with log-rank testing and Cox proportional hazards models were used, with outcomes assessed at 6 months, 1, 3, and 5 years. RESULTS: Ischemic stroke occurred in 10.0% of CAS vs 9.8% of CEA patients (cumulative probability 15.85% vs 14.07%; hazard ratio [HR] 1.179, 95% CI 1.045-1.329, P = .007). All-cause mortality was higher after CAS (21.70% vs 18.69%; HR 1.212, 95% CI 1.084-1.355, P = .001). Intraparenchymal hemorrhage was more frequent after CAS (2.11% vs 1.30%; HR 1.940, 95% CI 1.327-2.835, P < .001). Major bleeding rates were comparable (12.10% vs 11.88%; HR 1.130, P = .071). All standardized differences were <0.10 postmatching. CONCLUSION: In real-world practice, CAS for asymptomatic carotid stenosis was associated with modestly higher ischemic stroke, mortality, and intraparenchymal hemorrhage compared with CEA over 5 years, suggesting an association favoring CEA. Prospective studies are needed to establish definitive causal relationships.

Authors

Institutions

Publication Details

Journal
Neurosurgery
Published
2026-08-13
DOI
https://doi.org/10.1227/neu.0000000000004184
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Carotid Artery Stenting Versus Carotid Endarterectomy for Asymptomatic Carotid Stenosis: A Propensity Score–Matched Real-World Analysis

Ajay Malhotra, Dhairya A. Lakhani, Marco Colasurdo, Huanwen Alvin Chen et al.
Neurosurgery
Cerebrovascular and Carotid Artery Diseases
article

Carotid Artery Stenting Versus Carotid Endarterectomy for Asymptomatic Carotid Stenosis: A Propensity Score–Matched Real-World Analysis

Ajay Malhotra, Dhairya A. Lakhani, Marco Colasurdo, Huanwen Alvin Chen, Matthew K McIntyre, Dheeraj Gandhi, Jay Kakadiya
article en

Abstract

BACKGROUND AND OBJECTIVES: Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are established revascularization strategies for carotid stenosis, yet evidence comparing them in asymptomatic populations remains limited. The Carotid Revascularization Endarterectomy versus Stenting Trial-2 used a parallel-arm design and did not provide a direct head-to-head comparison of CAS vs CEA. This study evaluates real-world long-term outcomes of CAS compared directly with those of CEA in asymptomatic carotid stenosis. METHODS: Adults with asymptomatic carotid stenosis undergoing CAS or CEA between January 2016 and December 2024 were identified from the TriNetX US Collaborative Network. Patients with previous ischemic stroke, TIA, hemorrhage, or posterior-circulation stenosis were excluded. Propensity score matching (1:1) on demographics, comorbidities, and baseline antithrombotic medications yielded 5415 patients per cohort. Primary outcomes were all-cause mortality and ischemic stroke at 5 years; secondary outcomes included intraparenchymal hemorrhage and major bleeding. Kaplan-Meier analyses with log-rank testing and Cox proportional hazards models were used, with outcomes assessed at 6 months, 1, 3, and 5 years. RESULTS: Ischemic stroke occurred in 10.0% of CAS vs 9.8% of CEA patients (cumulative probability 15.85% vs 14.07%; hazard ratio [HR] 1.179, 95% CI 1.045-1.329, P = .007). All-cause mortality was higher after CAS (21.70% vs 18.69%; HR 1.212, 95% CI 1.084-1.355, P = .001). Intraparenchymal hemorrhage was more frequent after CAS (2.11% vs 1.30%; HR 1.940, 95% CI 1.327-2.835, P < .001). Major bleeding rates were comparable (12.10% vs 11.88%; HR 1.130, P = .071). All standardized differences were <0.10 postmatching. CONCLUSION: In real-world practice, CAS for asymptomatic carotid stenosis was associated with modestly higher ischemic stroke, mortality, and intraparenchymal hemorrhage compared with CEA over 5 years, suggesting an association favoring CEA. Prospective studies are needed to establish definitive causal relationships.

Neurosurgery
West Virginia University (US), University of Maryland, Baltimore (US), University of Maryland Medical Center (US), Yale New Haven Hospital (US), Johns Hopkins University (US), Oregon Health & Science University (US), Johns Hopkins Medicine (US), Blanchette Rockefeller Neurosciences Institute (US), Neurological Surgery (US)
National Institute of General Medical Sciences
Good health and well-being
Openalex Percentile: Top 10%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.